Meng, Q., Zhou, Y., Chen, P., Wang, J., Jin, Y., Li, Y., Chen, C., Qiu, H., Shen, Y., Qiao, Q., Liu, H., Huang, L., Xie, L., Deng, Y., Yang, L., Zhang, L., Li, X., Li, J., Tan, S., Zhang, T. (2026). A multicenter randomized phase II trial assessing the efficacy and safety of mCapOX plus cetuximab with mFOLFOX6 plus cetuximab as first-line treatment for
                    <i>RAS/BRAF</i>
                    wild-type metastatic colorectal cancer: Updated results from the CAPCET study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3598